vs
太平洋生物科学（ASMB）与Idaho Strategic Resources, Inc.（IDR）财务数据对比。点击上方公司名可切换其他公司
Idaho Strategic Resources, Inc.的季度营收约是太平洋生物科学的1.4倍（$14.6M vs $10.8M），Idaho Strategic Resources, Inc.净利率更高（64.3% vs -85.2%，领先149.5%），Idaho Strategic Resources, Inc.同比增速更快（92.0% vs 57.6%），Idaho Strategic Resources, Inc.自由现金流更多（$8.2M vs $-15.2M）
该公司是一家成立于2004年的美国生物科技企业，主要研发生产基因测序相关设备，同时也开展新型实时生物观测技术相关业务。目前拥有两大核心测序平台，分别是基于零模波导特性的单分子实时测序平台，以及结合天然核苷酸无痕连接技术的结合测序平台。
爱达荷战略资源公司是一家总部位于美国的自然资源企业，专注于关键战略矿产的勘探、开发与生产，主要在爱达荷州运营，产品覆盖稀土、金、银等品类，供应清洁能源、国防及工业制造等多个下游领域。
ASMB vs IDR — 直观对比
营收规模更大
IDR
是对方的1.4倍
$10.8M
营收增速更快
IDR
高出34.4%
57.6%
净利率更高
IDR
高出149.5%
-85.2%
自由现金流更多
IDR
多$23.3M
$-15.2M
损益表 — Q3 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $10.8M | $14.6M |
| 净利润 | $-9.2M | $9.4M |
| 毛利率 | — | 68.5% |
| 营业利润率 | -100.9% | 62.4% |
| 净利率 | -85.2% | 64.3% |
| 营收同比 | 57.6% | 92.0% |
| 净利润同比 | 4.3% | 220.6% |
| 每股收益（稀释后） | $-0.72 | $0.62 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ASMBIDR
| Q4 25 | — | $14.6M | ||
| Q3 25 | $10.8M | $11.1M | ||
| Q2 25 | $9.6M | $9.5M | ||
| Q1 25 | $9.4M | $7.3M | ||
| Q4 24 | $7.4M | $7.6M | ||
| Q3 24 | $6.8M | $6.2M | ||
| Q2 24 | $8.5M | $6.1M | ||
| Q1 24 | $5.8M | $5.9M |
净利润ASMBIDR
| Q4 25 | — | $9.4M | ||
| Q3 25 | $-9.2M | $3.0M | ||
| Q2 25 | $-10.2M | $2.8M | ||
| Q1 25 | $-8.8M | $1.6M | ||
| Q4 24 | — | $2.9M | ||
| Q3 24 | $-9.6M | $1.6M | ||
| Q2 24 | $-11.2M | $2.2M | ||
| Q1 24 | $-9.1M | $2.2M |
毛利率ASMBIDR
| Q4 25 | — | 68.5% | ||
| Q3 25 | — | 63.6% | ||
| Q2 25 | — | 57.8% | ||
| Q1 25 | — | 50.8% | ||
| Q4 24 | — | 53.3% | ||
| Q3 24 | — | 48.7% | ||
| Q2 24 | — | 50.2% | ||
| Q1 24 | — | 48.1% |
营业利润率ASMBIDR
| Q4 25 | — | 62.4% | ||
| Q3 25 | -100.9% | 23.4% | ||
| Q2 25 | -115.2% | 26.6% | ||
| Q1 25 | -105.5% | 19.3% | ||
| Q4 24 | — | 36.2% | ||
| Q3 24 | -160.1% | 23.4% | ||
| Q2 24 | -143.0% | 34.2% | ||
| Q1 24 | -185.5% | 36.3% |
净利率ASMBIDR
| Q4 25 | — | 64.3% | ||
| Q3 25 | -85.2% | 26.8% | ||
| Q2 25 | -105.9% | 29.2% | ||
| Q1 25 | -93.6% | 22.1% | ||
| Q4 24 | — | 38.5% | ||
| Q3 24 | -140.4% | 25.8% | ||
| Q2 24 | -130.7% | 35.2% | ||
| Q1 24 | -156.9% | 36.8% |
每股收益（稀释后）ASMBIDR
| Q4 25 | — | $0.62 | ||
| Q3 25 | $-0.72 | $0.20 | ||
| Q2 25 | $-1.33 | $0.20 | ||
| Q1 25 | $-1.17 | $0.12 | ||
| Q4 24 | — | $0.21 | ||
| Q3 24 | $-1.51 | $0.12 | ||
| Q2 24 | $-1.98 | $0.17 | ||
| Q1 24 | $-1.66 | $0.17 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $22.5M | — |
| 总债务越低越好 | — | $2.3M |
| 股东权益账面价值 | $182.7M | $108.2M |
| 总资产 | $240.0M | $116.2M |
| 负债/权益比越低杠杆越低 | — | 0.02× |
8季度趋势，按日历期对齐
现金及短期投资ASMBIDR
| Q4 25 | — | — | ||
| Q3 25 | $22.5M | — | ||
| Q2 25 | $24.0M | — | ||
| Q1 25 | $23.4M | — | ||
| Q4 24 | $38.3M | — | ||
| Q3 24 | $28.5M | — | ||
| Q2 24 | $19.2M | $6.3M | ||
| Q1 24 | $18.7M | $5.3M |
总债务ASMBIDR
| Q4 25 | — | $2.3M | ||
| Q3 25 | — | $3.0M | ||
| Q2 25 | — | $3.3M | ||
| Q1 25 | — | $3.7M | ||
| Q4 24 | — | $1.7M | ||
| Q3 24 | — | $2.9M | ||
| Q2 24 | — | $2.7M | ||
| Q1 24 | — | $3.3M |
股东权益ASMBIDR
| Q4 25 | — | $108.2M | ||
| Q3 25 | $182.7M | $74.3M | ||
| Q2 25 | $18.1M | $49.3M | ||
| Q1 25 | $27.1M | $39.8M | ||
| Q4 24 | $33.4M | $37.7M | ||
| Q3 24 | $26.0M | $33.1M | ||
| Q2 24 | $34.7M | $25.4M | ||
| Q1 24 | $32.6M | $21.6M |
总资产ASMBIDR
| Q4 25 | — | $116.2M | ||
| Q3 25 | $240.0M | $83.1M | ||
| Q2 25 | $80.8M | $57.7M | ||
| Q1 25 | $99.0M | $48.1M | ||
| Q4 24 | $119.2M | $44.0M | ||
| Q3 24 | $100.3M | $40.8M | ||
| Q2 24 | $115.3M | $32.2M | ||
| Q1 24 | $119.9M | $28.7M |
负债/权益比ASMBIDR
| Q4 25 | — | 0.02× | ||
| Q3 25 | — | 0.04× | ||
| Q2 25 | — | 0.07× | ||
| Q1 25 | — | 0.09× | ||
| Q4 24 | — | 0.05× | ||
| Q3 24 | — | 0.09× | ||
| Q2 24 | — | 0.11× | ||
| Q1 24 | — | 0.15× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-15.1M | $10.7M |
| 自由现金流经营现金流 - 资本支出 | $-15.2M | $8.2M |
| 自由现金流率自由现金流/营收 | -140.7% | 56.0% |
| 资本支出强度资本支出/营收 | 0.4% | 17.7% |
| 现金转化率经营现金流/净利润 | — | 1.15× |
| 过去12个月自由现金流最近4个季度 | — | $12.4M |
8季度趋势，按日历期对齐
经营现金流ASMBIDR
| Q4 25 | — | $10.7M | ||
| Q3 25 | $-15.1M | $2.4M | ||
| Q2 25 | $-16.8M | $3.5M | ||
| Q1 25 | $-23.4M | $2.4M | ||
| Q4 24 | $-51.1M | $3.2M | ||
| Q3 24 | $-15.2M | $2.5M | ||
| Q2 24 | $-17.1M | $2.6M | ||
| Q1 24 | $-18.4M | $2.6M |
自由现金流ASMBIDR
| Q4 25 | — | $8.2M | ||
| Q3 25 | $-15.2M | $709.8K | ||
| Q2 25 | — | $2.5M | ||
| Q1 25 | — | $1.0M | ||
| Q4 24 | $-51.1M | $2.1M | ||
| Q3 24 | — | $1.9M | ||
| Q2 24 | $-17.1M | $2.4M | ||
| Q1 24 | $-18.4M | $2.3M |
自由现金流率ASMBIDR
| Q4 25 | — | 56.0% | ||
| Q3 25 | -140.7% | 6.4% | ||
| Q2 25 | — | 26.5% | ||
| Q1 25 | — | 13.8% | ||
| Q4 24 | -695.2% | 28.0% | ||
| Q3 24 | — | 30.4% | ||
| Q2 24 | -200.6% | 38.7% | ||
| Q1 24 | -317.7% | 38.3% |
资本支出强度ASMBIDR
| Q4 25 | — | 17.7% | ||
| Q3 25 | 0.4% | 15.3% | ||
| Q2 25 | 0.0% | 10.8% | ||
| Q1 25 | 0.0% | 19.4% | ||
| Q4 24 | 0.4% | 13.6% | ||
| Q3 24 | 0.0% | 9.8% | ||
| Q2 24 | 0.2% | 4.3% | ||
| Q1 24 | 0.2% | 5.5% |
现金转化率ASMBIDR
| Q4 25 | — | 1.15× | ||
| Q3 25 | — | 0.81× | ||
| Q2 25 | — | 1.28× | ||
| Q1 25 | — | 1.50× | ||
| Q4 24 | — | 1.08× | ||
| Q3 24 | — | 1.56× | ||
| Q2 24 | — | 1.22× | ||
| Q1 24 | — | 1.19× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
